Skip to main content

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 469))

Abstract

Two kinetically different pathways that generate prostaglandin (PG) from endogenous arachidonic acid, the immediate and delayed phases, imply the recruitment of different sets of biosynthetic enzymes, the expression and activation of which are tightly regulated by distinct transmembrane signalings. The immediate phase of PG biosynthesis occurs within several minutes of stimulation, is elicited by agonists that mobilize intracellular Ca2+ and is characterized by a burst release of arachidonic acid (AA) initiated by Ca2+-dependent phospholipase A2 (PLA2) which is subsequently converted to bioactive PGs by the sequential actions of cyclooxygenase (COX) and terminal PG synthases. The delayed phase of PG biosynthesis is accompanied by the continuous supply of AA and its conversion to PGs, often PGE2, over long culture periods following growth or pro-inflammatory stimuli. Here we report the molecular identification of the PLA2 and COX isozymes involved in the PG biosynthetic pathway in rat fibroblasts and hepatocytes and provide evidence that type HA secretory PLA2 (sPLA2-IIA) plays an augmentative role in prolonged PG production following proinflammatory stimuli.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Refferences

  1. H. Kuwata, Y. Nakatani, M. Murakami, and I. Kudo. Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts. J. Biol. Chem.273: 1733 (1998)

    Article  PubMed  CAS  Google Scholar 

  2. J.A. Tischfield. A reassessment of the low molecular weight phospholipase A2 gene family in mammals. J. Biol. Chem.272: 17247 (1997)

    Article  PubMed  CAS  Google Scholar 

  3. H. Suga, H., M. Murakami, I. Kudo, and K. Inoue. Participation in cellular prostaglandin synthesis of type II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan. Eur. J. Biochem.218: 807 (1993)

    Google Scholar 

  4. M. Murakami, I. Kudo, and K. Inoue. Molecular nature of phospholipase A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells: possible participation of cytosolic and extracellular type II phospholipases A2. J. Biol. Chem.268: 839 (1993)

    CAS  Google Scholar 

  5. M. Murakami, Y. Nakatani, and I. Kudo. Type II secretory phsopholipase A2 associated with cell surfaces via C-terminal heparin-binding lysine residues augments stimulus-initiated delayed prostaglandin generation. J. Biol. Chem.271: 30041 (1996)

    Article  PubMed  CAS  Google Scholar 

  6. M. Murakami, I. Kudo and K. Inoue. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian group II phospholipase A2. FEBS Lett.294: 247 (1991)

    Article  PubMed  CAS  Google Scholar 

  7. M. MacPhee, K.P. Chepenik, R. Liddell, K.K. Nelson, L.D. Siracusa, and A.M. Buchberg. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of Apc Mim-induced intestinal neoplasia. Cell 81:957(19

    Google Scholar 

  8. M. Murakami, H. Kuwata, H., Y. Amakasu, S. Shimbara, Y. Nakatani, G. Atsumi, and I. Kudo. Prostaglandin E2 amplifies cytosolic phospholipase A2 and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells: enhancement by secretory phospholipase A2. J. Biol. Chem.272: 19891 (1997)

    Article  PubMed  CAS  Google Scholar 

  9. M. Murakami, Y. Nakatani, G. Atsumi, K. Inoue, and I. Kudo. Regulatory functions of phospholipase A2. Crit. Rev. Immunol.17: 225 (1997)

    Article  PubMed  CAS  Google Scholar 

  10. G. Atsumi, M. Murakami, M. Tajima, S. Shimbara, N. Hara, and I. Kudo. The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. Biochim. Biophys. Acta1349: 43 (1997)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kuwata, H., Sawada, H., Murakami, M., Kudo, I. (1999). Role of Type IIA Secretory Phospholipase A2 in Arachidonic Acid Metabolism. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4793-8_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7171-7

  • Online ISBN: 978-1-4615-4793-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics